Giant Biogene Holding Co., Ltd. (HKG: 2367)
Hong Kong
· Delayed Price · Currency is HKD
50.60
-0.65 (-1.27%)
Dec 27, 2024, 11:40 AM HKT
Giant Biogene Holding Revenue
Giant Biogene Holding had revenue of 2.54B CNY in the half year ending June 30, 2024, with 157.94% growth. This brings the company's revenue in the last twelve months to 4.46B, up 49.36% year-over-year. In the year 2023, Giant Biogene Holding had annual revenue of 3.52B with 49.05% growth.
Revenue (ttm)
4.46B CNY
Revenue Growth
+49.36%
P/S Ratio
10.20
Revenue / Employee
3.83M CNY
Employees
1,164
Market Cap
50.71B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.52B | 1.16B | 49.05% |
Dec 31, 2022 | 2.36B | 811.96M | 52.30% |
Dec 31, 2021 | 1.55B | 362.01M | 30.41% |
Dec 31, 2020 | 1.19B | 233.78M | 24.44% |
Dec 31, 2019 | 956.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition